EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the role of microbiome in cystic fibrosis clinical outcomes through a mediation analysis

Seda Sevilay Koldaş iD, Osman Uğur Sezerman iD, Emel Timuçin iD

mSystems · 2025

DOI: 10.1128/msystems.00196-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, 2025. Verfasst von Seda Sevilay Koldaş und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Bioinformatics, School of Health Science, Acıbadem Mehmet Ali Aydınlar University, , Istanbul, Turkey. Hauptthemen laut MEDLINE: Cystic Fibrosis, Microbiota. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human microbiome plays a crucial role in host health and disease by mediating the impact of environmental factors on clinical outcomes. Mediation analysis is a valuable tool for dissecting these complex relationships. However, existing approaches are primarily designed for cross-sectional studies. Modern clinical research increasingly utilizes long follow-up periods, leading to complex data structures, particularly in metagenomic studies. To address this limitation, we introduce a novel mediation framework based on structural equation modeling that leverages linear mixed-effects models using penalized quasi-likelihood estimation with a debiased lasso. We applied this framework to a 16S rRNA sputum microbiome data set collected from patients with cystic fibrosis over 10 years to investigate the mediating role of the microbiome in the relationship between clinical states, disease aggressiveness phenotypes, and lung function. We identified richness as a key mediator of lung function. Specifically, Streptococcus was found to be significantly associated with mediating the decline in lung function on treatment compared to exacerbation, while Gemella was associated with the decline in lung function on recovery. This approach offers a powerful new tool for understanding the complex interplay between microbiome and clinical outcomes in longitudinal studies, facilitating targeted microbiome-based interventions. IMPORTANCE Understanding the mechanisms by which the microbiome influences clinical outcomes is paramount for realizing the full potential of microbiome-based medicine, including diagnostics and therapeutics. Identifying specific microbial mediators not only reveals potential targets for novel therapies and drug repurposing but also offers a more precise approach to patient stratification and personalized interventions. While traditional mediation analyses are ill-equipped to address the complexities of longitudinal metagenomic data, our framework directly addresses this gap, enabling robust investigation of these increasingly common study designs. By applying this framework to a decade-long cystic fibrosis study, we have begun to unravel the intricate relationships between the sputum microbiome and lung function decline across different clinical states, yielding insights that were previously unknown.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisMicrobiotaHumansSputumFemaleMaleRNA, Ribosomal, 16SAdultLung

Stichwörter der Autor:innen

cystic fibrosishigh-dimensionallinear mixed effects modellongitudinal datamediation analysisstructural equation modeling

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Biostatistics and Bioinformatics, School of Health Science, Acıbadem Mehmet Ali Aydınlar University, , Istanbul, Turkey.
  • Biostatistics and Bioinformatics, School of Health Science, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
  • Molecular Biology and Genetics, Faculty of Science, Gebze Technical University, Kocaeli, Turkey.

ORCID-Profile: Seda Sevilay Koldaş, Osman Uğur Sezerman, Emel Timuçin

Zitieren

APA

Koldaş, S. S., Sezerman, O. U., & Timuçin, E. (2025). Exploring the role of microbiome in cystic fibrosis clinical outcomes through a mediation analysis. mSystems. https://doi.org/10.1128/msystems.00196-25

Vancouver

Koldaş SS, Sezerman OU, Timuçin E. Exploring the role of microbiome in cystic fibrosis clinical outcomes through a mediation analysis. mSystems. 2025. doi:10.1128/msystems.00196-25

BibTeX
@article{Kolda2025,
  author = {Koldaş, Seda Sevilay and Sezerman, Osman Uğur and Timuçin, Emel},
  title = {Exploring the role of microbiome in cystic fibrosis clinical outcomes through a mediation analysis},
  journal = {mSystems},
  year = {2025},
  doi = {10.1128/msystems.00196-25}
}
Kostenlos starten →